MUC1 and neoplasm: Efficient tumor elimination also utilizes TACA-specific CD8+ cytotoxic T cells, particularly since tumor-shed, aberrantly glycosylated MUC1 can interfere with tumor targeting by anti-MUC1 antibodies.